Dr. Moira Gunn speaks with Robert "Al" Beardsley, the President and CEO of Kereos. He talks about their cancer research -- and how it fits in the field of nanotech. Then on the BioIssue of the Week, David Duncan will give us the expert's view on a reasonable timeline to expect results from today's stem cell research.